Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1746-6148

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas ; volume:10 ; number:1 ; day:26 ; month:11 ; year:2014 ; pages:1-10 ; date:12.2014
BMC veterinary research ; 10, Heft 1 (26.11.2014), 1-10, 12.2014

Creator: Figueira, Ana Catarina

Contributor: Gomes, Catarina
de Oliveira, Joana Tavares
Vilhena, Hugo
Carvalheira, Júlio
de Matos, Augusto JF
Pereira, Patrícia Dias
Gärtner, Fátima
SpringerLink (Online service)

DOI: 10.1186/s12917-014-0270-z

URN: urn:nbn:de:1111-2016080554969

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Figueira, Ana Catarina
Gomes, Catarina
de Oliveira, Joana Tavares
Vilhena, Hugo
Carvalheira, Júlio
de Matos, Augusto JF
Pereira, Patrícia Dias
Gärtner, Fátima
SpringerLink (Online service)

Other Objects (12)

Aberrant E-cadherin staining patterns in invasive mammary carcinoma

Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas

Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study

Molecular Characterisation of Feline Mammary Tumours

Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer

MMTV-related sequences in feline breast carcinomas

Lymphatic vessels assessment in feline mammary tumours

Expression of HIF-1α and VEGF in feline mammary gland carcinomas: association with pathological characteristics and clinical outcomes

Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer

Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas

Significance of sphingosine kinase 1 expression in feline mammary tumors

Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways

Aberrant E-cadherin staining patterns in invasive mammary carcinoma

Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas

Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study

Molecular Characterisation of Feline Mammary Tumours

Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer

MMTV-related sequences in feline breast carcinomas

Lymphatic vessels assessment in feline mammary tumours

Expression of HIF-1α and VEGF in feline mammary gland carcinomas: association with pathological characteristics and clinical outcomes

Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer

Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas

Significance of sphingosine kinase 1 expression in feline mammary tumors

Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways

Aberrant E-cadherin staining patterns in invasive mammary carcinoma

Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas

Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study

Molecular Characterisation of Feline Mammary Tumours

Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer

MMTV-related sequences in feline breast carcinomas

Lymphatic vessels assessment in feline mammary tumours

Expression of HIF-1α and VEGF in feline mammary gland carcinomas: association with pathological characteristics and clinical outcomes

Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer

Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas

Significance of sphingosine kinase 1 expression in feline mammary tumors

Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Aberrant E-cadherin staining patterns in invasive mammary carcinoma

Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas

Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study

Molecular Characterisation of Feline Mammary Tumours

Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer

MMTV-related sequences in feline breast carcinomas

Lymphatic vessels assessment in feline mammary tumours

Expression of HIF-1α and VEGF in feline mammary gland carcinomas: association with pathological characteristics and clinical outcomes

Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer

Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas

Significance of sphingosine kinase 1 expression in feline mammary tumors

Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways

Aberrant E-cadherin staining patterns in invasive mammary carcinoma

Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas

Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study

Molecular Characterisation of Feline Mammary Tumours

Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer

MMTV-related sequences in feline breast carcinomas

Lymphatic vessels assessment in feline mammary tumours

Expression of HIF-1α and VEGF in feline mammary gland carcinomas: association with pathological characteristics and clinical outcomes

Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer

Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas

Significance of sphingosine kinase 1 expression in feline mammary tumors

Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways

Aberrant E-cadherin staining patterns in invasive mammary carcinoma

Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas

Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study

Molecular Characterisation of Feline Mammary Tumours

Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer

MMTV-related sequences in feline breast carcinomas

Lymphatic vessels assessment in feline mammary tumours

Expression of HIF-1α and VEGF in feline mammary gland carcinomas: association with pathological characteristics and clinical outcomes

Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer

Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas

Significance of sphingosine kinase 1 expression in feline mammary tumors

Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways

Related objects

Reset password